Cite
HARVARD Citation
Xie, F. et al. (2022). Cyclin‐dependent kinase 12‐mediated super‐enhancers as promising targets in cancer therapy. Clinical and translational discovery. 2 (4), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Xie, F. et al. (2022). Cyclin‐dependent kinase 12‐mediated super‐enhancers as promising targets in cancer therapy. Clinical and translational discovery. 2 (4), p. n/a. [Online].